Blue Zone Wealth Advisors’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,000
Closed -$11K 90
2023
Q4
$11K Hold
5,000
﹤0.01% 81
2023
Q3
$12.3K Hold
5,000
0.01% 79
2023
Q2
$39.1K Hold
5,000
0.02% 76
2023
Q1
$32.9K Hold
5,000
0.02% 79
2022
Q4
$29.1K Hold
5,000
0.02% 80
2022
Q3
$25K Hold
5,000
0.01% 82
2022
Q2
$22K Hold
5,000
0.01% 85
2022
Q1
$42K Hold
5,000
0.02% 95
2021
Q4
$48K Hold
5,000
0.02% 101
2021
Q3
$60K Hold
5,000
0.02% 98
2021
Q2
$75K Hold
5,000
0.03% 86
2021
Q1
$83K Hold
5,000
0.04% 81
2020
Q4
$85K Hold
5,000
0.04% 74
2020
Q3
$186K Hold
5,000
0.11% 68
2020
Q2
$114K Hold
5,000
0.06% 63
2020
Q1
$44K Hold
5,000
0.04% 45
2019
Q4
$74K Buy
+5,000
New +$63.7K 0.05% 43

Other funds holding MESO

Blue Zone Wealth Advisors's MESO Position: Q1 2024 in Review

Blue Zone Wealth Advisors sold out of Mesoblast (MESO) in Q1 2024, closing a stake of 5,000 shares — an estimated $11K sold.

Blue Zone Wealth Advisors first reported a position in MESO in Q4 2019 and held it in 17 quarters. The position peaked at $186K in Q3 2020. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

  • Blue Zone Wealth Advisors reported no remaining Mesoblast position as of Q1 2024 after selling out during the quarter.
  • Blue Zone Wealth Advisors sold 5,000 Mesoblast shares in Q1 2024, an estimated $11K.
  • Blue Zone Wealth Advisors first reported a position in Mesoblast in Q4 2019 and held it in 17 quarters.
  • Blue Zone Wealth Advisors's Mesoblast position peaked at $186K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on Blue Zone Wealth Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.